share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Director Hannan Kathy Hopinkah

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Director Hannan Kathy Hopinkah

Ginkgo Bioworks | 4:持股變動聲明-董事 Hannan Kathy Hopinkah
美股sec公告 ·  06/15 04:31
牛牛AI助理已提取核心訊息
Kathy Hopinkah Hannan, associated with Ginkgo Bioworks Holdings, Inc., executed a significant stock transaction on June 12, 2024. Hannan acquired 105,263 shares of Ginkgo Bioworks' Class A Common Stock through the exercise or conversion of derivative securities. Following this transaction, Hannan's direct holdings in the company amount to a total of 167,249 shares. The transaction reflects a notable change in Hannan's investment in the company, and it could be of interest to investors monitoring insider activity within Ginkgo Bioworks.
Kathy Hopinkah Hannan, associated with Ginkgo Bioworks Holdings, Inc., executed a significant stock transaction on June 12, 2024. Hannan acquired 105,263 shares of Ginkgo Bioworks' Class A Common Stock through the exercise or conversion of derivative securities. Following this transaction, Hannan's direct holdings in the company amount to a total of 167,249 shares. The transaction reflects a notable change in Hannan's investment in the company, and it could be of interest to investors monitoring insider activity within Ginkgo Bioworks.
Kathy Hopinkah Hannan於2024年6月12日與Ginkgo Bioworks Holdings, Inc.有關,進行了一項重大的股票交易。Hannan通過行權或轉換衍生證券獲得了Ginkgo Bioworks的105,263股A類普通股。在此交易後,Hannan在該公司的直接持股總額爲167,249股。該交易反映了Hannan在公司內的投資發生了顯著變化,對於監控Ginkgo Bioworks內部活動的投資者可能具有興趣。
Kathy Hopinkah Hannan於2024年6月12日與Ginkgo Bioworks Holdings, Inc.有關,進行了一項重大的股票交易。Hannan通過行權或轉換衍生證券獲得了Ginkgo Bioworks的105,263股A類普通股。在此交易後,Hannan在該公司的直接持股總額爲167,249股。該交易反映了Hannan在公司內的投資發生了顯著變化,對於監控Ginkgo Bioworks內部活動的投資者可能具有興趣。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。